On Apr. 29, 2021, Moderna announced it was making new funding commitments to increase supply at its owned and partnered manufacturing facilities, which it expected will increase global 2022 capacity to up to 3 billion doses of its COVID-19 vaccine, depending upon the mix between the authorized Moderna COVID-19 Vaccine at the 100 ﾵg dose level and potentially lower doses of the Companyﾒs variant booster candidates and pediatric vaccines, if authorized.